Relmada Therapeutics
RLMD
#9904
Rank
โ‚ฌ11 M
Marketcap
0,36ย โ‚ฌ
Share price
4.60%
Change (1 day)
-86.86%
Change (1 year)

Relmada Therapeutics (RLMD) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ51.98 Million

According to Relmada Therapeutics's latest financial reports the company has โ‚ฌ51.98 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Relmada Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ0.13 B-26.1%
2021-12-31โ‚ฌ0.18 B96.56%
2020-12-31โ‚ฌ95.19 M
2019-06-30โ‚ฌ8.09 M323%
2018-06-30โ‚ฌ1.91 M27.96%
2017-06-30โ‚ฌ1.49 M-80.43%
2016-06-30โ‚ฌ7.63 M-61.85%
2015-06-30โ‚ฌ20.02 M6.86%
2014-06-30โ‚ฌ18.73 M
2013-08-31โ‚ฌ0.01 M61.8%
2012-08-31โ‚ฌ0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.86 B 1,567.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ0.97 B 1,769.43%๐Ÿ‡บ๐Ÿ‡ธ USA